Preprint · OA
via OpenAlex
Age-Related Macular Degeneration
New England Journal of Medicine · 2021 · ▲ 168 citations
Abstract
Age-related macular degeneration is the leading cause of vision loss in older persons in industrialized nations. Micronutrient supplementation can reduce the risk of progression to advanced AMD. Treatment of neovascular AMD with anti–vascular endothelial growth factor pharmacotherapy reduces vision loss.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1056/nejmcp2102061
- Canonical
- link ↗
- Fetched
- 2026-10-19 MST
Cite this
APA
Apte, R.S. (2021). Age-Related Macular Degeneration. <em>New England Journal of Medicine</em>. https://doi.org/10.1056/nejmcp2102061
Vancouver
Apte RS. Age-Related Macular Degeneration. New England Journal of Medicine. 2021. doi:10.1056/nejmcp2102061.
BibTeX
@unpublished{rajendra2021AgeRel,
title = {Age-Related Macular Degeneration},
author = {Rajendra S. Apte},
journal = {New England Journal of Medicine},
year = {2021},
doi = {10.1056/nejmcp2102061},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nature reviews. Immunology 2013
Preprint · OA
Immunology of age-related macular degeneration
Drugs 2008
Citation only
Neovascular Age-Related Macular Degeneration
Experimental Eye Research 2005
Citation only
Mouse models of age-related macular degeneration
Elsevier eBooks 2021
Preprint · OA
Age-Related Macular Degeneration
American Journal of Ophthalmology 2004
Citation only
Age-Related macular degeneration
Aging Clinical and Experimental Research 1993
Citation only